CClinicalTrials.gg
CompletedNCT06769321Updated Jan 13, 2025

Automatic Thermomechanical Massage Bed for Acute Pain Relief for Chronic Nonspecific Low Back Pain

An interventional study of Automatic Thermo-mechanical Massage Bed in Chronic Non-specific Low Back Pain, sponsored by The City College of New York. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-01-13.

Sponsored by The City College of New York · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Jul 2024, 2 years 2 months ago, and no results have been posted to the registry.
  • Registered 7 months after the study started (first participant enrolled Jun 2024, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This prospective, double-blinded, sham-control, parallel-arm, randomized pilot trial will recruit n=40 participants, ages 18-65 (inclusive), with chronic low back pain (LBP) in the lower region, to be randomly assigned using 1:1 randomization method to receive a 40-minute single session of either active or sham Automated Thermo-mechanical Therapy (ATT). All research procedures, including informed consent, ATT session, and pre- and post-ATT assessments, will be completed in one single session.

02

Conditions studied

  • Chronic Non-specific Low Back Pain

Keywords

  • Chronic Pain
  • Low back Pain
  • Automatic Thermo-mechanical Therapy
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's enrollment of 40 is below the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

The City College of New York is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Between the ages of 18 and 65
  • Has had chronic non-specific lower back pain persisting for 12 weeks or more
  • Conversational level of English

Exclusion criteria

Exclusion Criteria:

  • Contraindications to mechanical manipulation of the back
  • History of back surgery within the past three years
  • Recent back injury
  • Presence of back implants or active implanted devices
  • Low back pain resulting from other specific conditions (e.g., infection, neoplasm)
  • Sensitivity to heat
  • Circulatory insufficiency
  • Heart disease
  • Pregnant or breastfeeding
  • Individuals with a history of substance use disorder
  • Body weight over 298 lbs (135 kg)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Active Automatic Thermomechanical Therapy

    This device delivers thermomechanical therapy to the lower back for 40 minutes

    Device: Automatic Thermo-mechanical Massage Bed

  • Sham comparator
    Sham Automatic Thermomechanical Therapy

    The comparator device is a sham device that has the same outer appearance as the investigational device. Throughout the entire massage session, the intensity will be set to a level below 1, in areas unrelated to where the major muscles causing lower back pain are located, minimizing the actual massage effect. The thermal component will be turned off entirely.

    Device: Automatic Thermo-mechanical Massage Bed

Interventions

  • DeviceAutomatic Thermo-mechanical Massage Bed

    The MASTER V6 (Master series, CGM MB-1701, CERAGEM Co. Ltd., Cheonan, Korea) used in this study is a commercially available automated thermo-mechanical therapy device that combines mechanical spinal stimulation with far-infrared (FIR) heat treatment.

06

What researchers measure

Primary outcomes

  1. The 100mm Visual Analogue Scale for Pain

    The VAS-P100 is a unidimensional measure of pain intensity, used to record patients' pain progression or compare pain severity between patients. The 100-mm VAS-P is a straight horizontal line of fixed length of 100 mm. The ends are defined as the extreme limits of the parameter to be measured (pain) orientated from the left (best) to the right (worst). The participant marks on the line the point that they feel represents their perception of their current state. The score is determined by measuring in millimeters from the left-hand end of the line to the point that the patient marks

    Time frame: Immediately before and immediately after intervention

Secondary outcomes

  1. Roland-Morris Disability Questionnaire

    The Roland-Morris is a 24-item self-report questionnaire about how low-back pain affects functional activities. Total score can range from 0 (no disability) to 24 (severe disability). The RMDQ is scored by adding up the number of items the patient checks.

    Time frame: Immediately before intervention

  2. McGill Pain Questionnaire

    This questionnaire is used to evaluate a person experiencing significant pain, to monitor the pain over time and to determine the effectiveness of any intervention. The questionnaire evaluates three different domains: 1) What does the pain look like?; 2) How does your pain change with time?; 3) How strong is your pain?

    Time frame: Immediately before intervention and immediately after intervention

  3. State-Trait Anxiety Inventory

    This questionnaire is widely used to measure the state and trait components of anxiety

    Time frame: Immediately before and immediately after intervention

  4. 5-point Verbal Rating Scale for Pain Relief

    Verbal rating scales about pain relief on a 5-point rating scale: none= 0, slight= 1, moderate= 2, good= 3, complete relief= 4. (Administered only at the post-ATMB intervention)28

    Time frame: Immediately after intervention

  5. Modified-Modified Schöber Test

    This is a physical examination used to measure the ability of a patient to flex the lower back. The patient is standing, and the examiner marks both posterior superior iliac spine (PSIS) and then draws a horizontal line at the center of both marks. A second line is marked 15 cm above the first line. The patient is then instructed to flex forward without bending the knees as if attempting to touch his/her toes, examiner re-measures the distance between the top and bottom line

    Time frame: Immediately before and immediately after intervention

07

Study locations

1 site
  • The Center for Discovery and Innovation
    New York, New York 10031, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06769321
Lead sponsor
The City College of New York
Responsible party
Marom Bikson (Professor, The City College of New York) — Principal investigator
First posted
Jan 10, 2025
Start date
Jun 5, 2024
Primary completion
Jul 27, 2024
Completion
Jul 27, 2024
Last update
Jan 13, 2025

Study contacts

Marom Bikson, PhD
principal investigator · The City College of New York

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion